Thermo Fisher Scientific Launches Next-Generation Spectral Flow Cytometry Beads
The beads offer multispecies compatibility and cell-like performance to reduce false positives in flow cytometry analysis.
The beads offer multispecies compatibility and cell-like performance to reduce false positives in flow cytometry analysis.
Greer Massey, PhD, chief scientific officer at Molecular Designs, shares insights on how labs are affected by the rule’s reversal and how they can prepare for future regulatory changes.
Johns Hopkins-led study identifies protein signature with 98% accuracy in distinguishing ALS patients from healthy individuals and those with other neurological diseases.
CURECA and STAgora technologies aim to eliminate manual intervention in molecular testing workflows and provide actionable diagnostic data insights.
A recent poll highlights growing interest in host response testing for sepsis. Immunexpress CEO Rollie Carlson discusses the findings and the future of rapid diagnostics.